Alexander Lekhtman

Psilocybin Helped Doctors and Nurses Who Worked Through the Pandemic

Many doctors and nurses suffered severe mental health impacts after working through the worst days of the COVID-19 pandemic, including…

December 10, 2024

VA Funds MDMA Study to Treat Veterans’ PTSD and Alcohol Use Disorder

The United States Department of Veterans Affairs (VA) is sponsoring historic research to treat veterans with MDMA. On December 3,…

December 5, 2024

With Winter Coming, Cities’ Emergency Shelter Plans Vary Wildly

As temperatures drop around the country, cities and counties have an even more urgent imperative to shelter thousands of people…

December 3, 2024

“May Launch a Substitution War”—Trump’s China Tariffs and Fentanyl

In what feels like a rerun of an old episode, President-elect Donald Trump has promised to impose new trade tariffs…

November 27, 2024

Syringe Program in Fargo, North Dakota, Survives Narrow Vote

A syringe service program in Fargo, North Dakota, has narrowly survived a vote after coming under attack. On November 25,…

November 26, 2024

The Overdose Crisis Was Ignored in This Election Cycle

The overdose crisis claims over 100,000 lives each year in the United States, but has received very little attention from…

November 5, 2024

Denver Weighs Removing Restrictions on Syringe Programs

Lawmakers in Denver, Colorado, are considering improving sryinge access, by allowing more syringe service programs (SSP) to open and removing…

October 31, 2024

Drug Policy Questions on the Ballot Across the US

As Donald Trump and Kamala Harris make their final dashes through battleground states, polls show an agonizingly close presidential race.…

October 30, 2024

Where Harm Reduction Stands Around the World in 2024

On October 29, Harm Reduction International released its latest biannual report on the status of harm reduction services around the…

October 29, 2024

San Joaquin County, CA, to Vote on Drug-Testing Public Benefit Recipients

Voters in San Joaquin County, California, are about to decide if people on public benefits should be drug-tested under threat…

October 24, 2024